Sign in

Thomas A. Wimsett

Director at JACK HENRY & ASSOCIATESJACK HENRY & ASSOCIATES
Board

About Thomas A. Wimsett

Independent director of Jack Henry & Associates, Inc. since 2012; age 61. Founder and Chairman of Merchant’s PACT with 35+ years in payments; prior roles include Executive Chairman of ControlScan (2014–2020), founder/CEO of Iron Triangle Payment Systems (sold to Vantiv in 2010), and President & CEO of National Processing Company (1999–2002). He chairs Jack Henry’s Risk & Compliance Committee, serves on the Audit Committee, and is designated an SEC “audit committee financial expert,” signaling strong financial oversight credentials .

Past Roles

OrganizationRoleTenureCommittees/Impact
ControlScan, Inc.Executive Chairman2014–2020Payment card compliance and security oversight; payments industry expertise
Iron Triangle Payment SystemsFounder, Chairman & CEOPre-2010; acquired 2010Built merchant acquiring processor sold to Vantiv in 2010
National Processing Company (now owned by Bank of America Corp.)President & CEO1999–2002Led processor; payments operating expertise
Town & Country Bank and Trust CompanyChairman and DirectorPrior role (dates not specified)Banking board leadership experience

External Roles

OrganizationRoleTenureNotes/Interlocks
Merchant’s PACTFounder & Chairman; Managing Partner; majority owner2012–presentReferral Partner Agreement with JKHY; Merchant’s PACT paid JKHY ~$86,000 in FY2025 referral fees
Revenue Management Solutions, LLCDirectorCurrentRMS uses JKHY enterprise payment solutions; FY2025 cash receipts < $10,000
Electronic Transaction Association (ETA)Director/advisory rolesPriorIndustry advocacy and standards (payments)
MasterCard U.S. Board; Discover Card; VisaPrior board/advisory rolesPriorCard network governance exposure

Board Governance

  • Independence: The Governance Committee determined Wimsett is independent under Nasdaq standards, notwithstanding relationships with Merchant’s PACT and RMS, given amounts are <1% of revenue and far below Nasdaq 5% threshold .
  • Committees and roles: Chair, Risk & Compliance Committee; Member, Audit Committee; designated Audit Committee Financial Expert (with Flanigan and Wilson) .
  • Attendance and engagement: Board held 4 regular and 2 special meetings; each director attended at least 75% of Board and committee meetings; independent directors held 4 executive sessions; all directors attended 2024 annual meeting .
  • Committee workload: FY2025 meetings — Audit: 13; Risk & Compliance: 7 — indicating substantial engagement in financial reporting and enterprise risk oversight .
  • Governance standards: Directors limited to ≤3 other public boards; age cap 72 (exceptions possible); 12-year limit for directors first elected after May 14, 2021; stock ownership guidelines and anti-hedging/pledging rules in place .

Fixed Compensation (Non-Employee Director, FY2025)

ComponentAmount (USD)Basis/Notes
Annual Board Retainer (cash)$70,000Standard non-employee retainer
Audit Committee Member Retainer$20,000Audit membership
Risk & Compliance Committee Member Retainer$15,000R&C membership
Risk & Compliance Committee Chair Retainer$25,000Chair premium
Total Cash Fees Earned (reported)$130,000Matches FY2025 director comp table

Performance Compensation (Director Equity; FY2025)

Non-employee directors receive annual time-based restricted stock units (RSUs), not performance-based awards; standard annual equity award target of ~$200,000; FY2025 grant date fair value reported for Wimsett was $199,870. As of June 30, 2025, each then-serving director (except Ms. Fiegel) held 1,159 unvested RSUs; directors may elect to defer RSUs under the Non-Employee Director Deferred Compensation Plan (one director elected deferral in FY2025; individual not identified) .

Equity ElementGrant DateInstrumentGrant-Date Fair ValueVesting
Annual Director GrantFY2025 cycleRSUs (time-based)$199,870Typically annual; time-based, not performance-conditioned

No options or non-equity incentive plan compensation for non-employee directors in FY2025; options column blank in director table .

Other Directorships & Interlocks

TypeCompanyNatureFY2025 Flow/AmountGovernance Treatment
Partner/ReferralMerchant’s PACTJKHY receives referral fees for customer referrals; Merchant’s PACT pays JKHY (no payments from JKHY to Merchant’s PACT)~$86,000 to JKHYConsidered in independence review; below Related Party threshold; did not impair independence
CustomerRevenue Management Solutions, LLCRMS (where Wimsett is a director) uses JKHY enterprise payments< $10,000 to JKHYReviewed; below thresholds; independence maintained

Expertise & Qualifications

  • Payments and fintech operator: Founder/CEO roles in merchant acquiring and payment security; extensive industry governance (ETA, networks) .
  • Risk oversight: Chair of Risk & Compliance overseeing enterprise risk, regulatory compliance, and cybersecurity; committee integrates inputs from CISO and management .
  • Financial oversight: Audit Committee member; designated “audit committee financial expert,” evidencing strong accounting/financial reporting acumen .

Equity Ownership

HolderShares Beneficially Owned% OutstandingNotes
Thomas A. Wimsett39,875<1%Beneficial ownership table as of Sept 16, 2025
Unvested RSUs (director-level, as of 6/30/25)1,159N/AEach then-serving director (excl. Fiegel) held 1,159 unvested RSUs
Hedging/PledgingProhibitedCompany policy bans hedging, short sales, pledging by directors
Director Ownership Guideline5x annual cash retainerAll directors compliant or within 5-year window as of 6/30/25

Governance Assessment

  • Board effectiveness: Dual role as Risk & Compliance Chair and Audit Committee financial expert enhances oversight of enterprise risk, information security, regulatory compliance, and financial reporting—key areas for a bank tech vendor .
  • Independence and conflicts: Independence affirmed despite Merchant’s PACT referral arrangement and RMS customer relationship; amounts small (≤ ~$86k and < $10k), flows accrue to JKHY, and arrangements reviewed/approved under Related Party policy—mitigating conflict risk .
  • Engagement: Committee workloads (Audit: 13; R&C: 7) and ≥75% attendance demonstrate active participation; independent sessions held regularly, supporting robust governance .
  • Alignment: Director pay mix skews toward equity (annual ~$200k RSUs) plus cash retainers tied to committee responsibilities; ownership guidelines (5x retainer) and anti-hedging/pledging policy support shareholder alignment; as of 9/16/25 Wimsett beneficially owned 39,875 shares (<1%) .
  • RED FLAGS: Related-party exposure via Merchant’s PACT exists but is structurally favorable to JKHY (payments flow to JKHY) and quantitatively immaterial under policy thresholds; independence retained per Governance Committee—monitor for any expansion in scope or materiality over time .

Director Compensation (FY2025 Snapshot)

ItemAmount (USD)
Fees Earned or Paid in Cash$130,000
Stock Awards (RSUs) – grant date fair value$199,870
Total$329,870

Standard program components: Board retainer $70k; Committee retainers—Audit $20k, Risk & Compliance $15k; Chair premium—Risk & Compliance $25k; Annual equity ~$200k RSUs paid to non-employee directors .

Related-Party Exposure (Detailed)

  • Merchant’s PACT referral agreement (2016; amended 2019): Merchant’s PACT pays JKHY fees for referred consulting/services; FY2025 ~$86,000. No payments from JKHY to Merchant’s PACT under the agreement .
  • RMS customer relationship: FY2025 cash receipts < $10,000 .
  • Governance conclusion: Audited and reviewed per Related Party policy; below policy thresholds; independence maintained .

Say-on-Pay & Shareholder Feedback (Context)

  • 2024 Say-on-Pay support: 93% approval, indicating general investor alignment with compensation governance (executive program context) .

Notes on Policies Affecting Alignment

  • Stock ownership guidelines: Directors must own ≥5x annual cash retainer; compliance or within window as of June 30, 2025 .
  • Trading policy: Prohibits hedging, short sales, options, and pledging by directors .

All data above reflects the Jack Henry 2025 definitive proxy statement (DEF 14A) filed October 2, 2025. Citations indicate specific document sections.